Elenco degli articoli con argomento «cheratosi attinica»

Dermatologia

10 giu 2024

Severity of Local Skin Reactions

Topical 5-fluorouracil (5-FU)-containing treatments are effective for actinic keratosis (AK)

05 apr 2024

European consensus-based interdisciplinary guideline for diagnosis

A collaboration of multidisciplinary experts from the European Association of Dermato-Oncology, the European Dermatology Forum

20 feb 2024

Keratolytics can replace curettage in daylight photodynamic therapy

Methyl aminolevulinate (MAL) photodynamic therapy (PDT) is commonly used for field treatment of actinic keratoses (AKs)

26 set 2022

Campagna di sensibilizzazione sulla cheratosi attinica 'SEGNALI SULLA PELLE' navigation-next-alternate

Promossa da SIDeMaST con contributo
non condizionante di PIERRE-FABRE

13 set 2022

Campagna di sensibilizzazione e di screening “Segnali sulla pelle” navigation-next-alternate

Screening gratuito su prenotazione in tutta Italia: si parte da Milano il 23 settembre

11 lug 2022

Clinical evaluation of a short illumination

Photodynamic therapy (PDT) using daylight as the photoactivating light source (DL-PDT) is an effective treatment for actinic keratosis (AK).

06 giu 2022

How to Assess the Efficacy of Interventions for Actinic Keratosis ?

Actinic keratoses (AK) are common lesions of the skin caused by cumulative sun exposure.

28 mar 2022

Topical Pharmacotherapy for Actinic Keratoses

Actinic keratosis is caused by excessive lifetime sun exposure. It must be treated, regardless of thickness, because it is the biologic precursor of invasive squamous cell carcinoma, a potentially deadly malignancy.

05 ott 2021

A Randomized Double-Blind Parallel-Group Study

Actinic keratosis (AK) consists of skin lesions with a milder degree of keratinocytic atypia

01 ago 2021

Pierre Fabre AK navigation-next-alternate

AK Trattare oltre il visibile

03 mag 2021

Cold Atmospheric Plasma

Cold atmospheric plasma (CAP) has been clinically demonstrated to be an effective treatment for actinic keratosis (AK) in a number of case series.

03 mag 2021

Actinic cheilitis

Actinic cheilitis is a premalignant condition that can progress to squamous cell carcinoma with a higher propensity for metastasis than cutaneous squamous cell carcinoma.

03 mag 2021

Guidelines of care for the management

Actinic keratoses (AK) are rough scaly patches that arise on chronically ultraviolet-exposed skin and can progress to keratinocyte carcinoma.

09 feb 2021

The dermoscopic inverse approach significantly

A recently introduced dermoscopic method for the diagnosis of early lentigo maligna

17 nov 2020

DIAGNOSTIC ACCURACY OF DERMOSCOPY OF ACTINIC KERATOSIS: A SYSTEMATIC REVIEW

Dermoscopy is a tool that aids clinicians in the diagnosis of actinic keratosis;

03 nov 2020

Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial

Guidelines for photodynamic therapy (PDT) of actinic keratosis (AK) recommend pretreatment with curettage. The impact of curettage on cure rate is, however, not well established.

27 lug 2020

Lasers and intense pulsed light (IPL) association with cancerous lesions

The development and use of light and lasers for medical and cosmetic procedures has increased exponentially over the past decade.

31 mag 2020

The more the better? An appraisal of combination therapies for actinic keratosis

Actinic keratoses (AK) are common precancerous lesions of the skin.

02 dic 2019

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses,

Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, Bowen's disease (squamous cell carcinoma in situ), superficial and certain thin basal cell carcinomas.

22 ott 2019

Squamous cell carcinoma: pain as a clue to increased tumour diameter, increased invasion depth, the grade of differentiation, acantholysis and perineu

Pain may be associated with actinic keratosis (AK), intraepidermal carcinoma (IEC) and invasive squamous cell carcinoma (SCC), which may all display high‐risk features.